- Open Access
Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway
Journal of Experimental & Clinical Cancer Research volume 39, Article number: 115 (2020)
Correction to: J Exp Clin Cancer Res (2020) 39:79
Following the publication of the original article , it was noted that due to a typesetting error the Figs. 1 and 2 were not complete. In addition, Fig. 1B should be changed to Fig. 1b, and Fig. 4w should be corrected to Fig. 4e in the main text of the article.
In the section “SNCG is overexpressed in EOC tissue and correlated with poor prognosis in patients with HGSOC”, (p = 0.055, Fig. 1c) should be corrected to (p = 0.058, Fig. 1c).
The correct figures have been included in this correction, and the original article has been corrected.
Zhang J, et al. SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway. J Exp Clin Cancer Res. 2020;39:79. https://doi.org/10.1186/s13046-020-01589-9.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zhang, J., Liu, Xh., Li, C. et al. Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway. J Exp Clin Cancer Res 39, 115 (2020). https://doi.org/10.1186/s13046-020-01596-w